Clinical trial
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002307 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002307 |
|---|---|
| Title | A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients |
| Official title | A Double-Blind Comparison of Zidovudine (AZT) Versus Stavudine (d4T; BMY 27857) for the Treatment of Patients With HIV Infection Who Have Absolute CD4 Lymphocyte Counts Between 50 and 500 Cells/mm3 |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Stavudine, Zidovudine |
| Completion | Dec 1, 1994 |
| First posted | Aug 31, 2001 |
| Last update posted | Aug 5, 2011 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: